M&T Bank Corp Grows Stake in Charles River Laboratories International, Inc. $CRL

M&T Bank Corp significantly increased its stake in Charles River Laboratories International, Inc. during the fourth quarter of the prior year, boosting its holdings by 1,424.9% to 27,997 shares. Charles River Laboratories surpassed Q4 earnings estimates with $2.39 EPS and $994.23 million in revenue, while also providing FY2026 EPS guidance between $10.70 and $11.20. The company maintains a “Moderate Buy” consensus rating from analysts, with a target price of $205.36.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin